ZetaGen Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zetagen.com
Pilot Study of ZetaFuseâ„¢ Bone Graft for the Treatment of Cervical Degenerative Disc Disease
Not Applicable
Recruiting
- Conditions
- Myelopathy CervicalDisc DiseaseDisc DegenerationNeurological AbnormalityRadiculopathy, Cervical
- Interventions
- Device: Cervical Fusion (ZetaFuseâ„¢ Bone Graft)
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Zetagen Therapeutics, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT05971329
- Locations
- 🇦🇺
Prince of Wales Public Hospital, Randwick, New South Wales, Australia
🇦🇺Prince of Wales Private Hospital, Randwick, New South Wales, Australia
Evaluating ZetaMet Via Outpatient Local Intratumoral Injection Procedure to Treat Breast Cancer Bone Metastases in the Spine to Control Pain and Prevent Complications Such as Fracture
Phase 2
Active, not recruiting
- Conditions
- Metastatic Breast Cancer in the Spine
- Interventions
- Device: ZetaFuseâ„¢ Bone Graft
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Zetagen Therapeutics, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT05280067
- Locations
- 🇨🇦
Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
🇨🇦McGill University Health Center, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath